Does Total Implantability Reduce Infection With the Use of a Left Ventricular Assist Device? The LionHeart Experience in Europe
- 31 March 2007
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 26 (3), 219-229
- https://doi.org/10.1016/j.healun.2006.12.007
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Costs for Heart Failure With Normal vs Reduced Ejection FractionArchives of Internal Medicine, 2006
- Managing Device Infections: Are We Progressing or Is Infection an Insurmountable Obstacle?ASAIO Journal, 2005
- Infection in permanent circulatory support: Experience from the REMATCH trialThe Journal of Heart and Lung Transplantation, 2004
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001
- Ventricular Assist Devices as a Bridge to Cardiac TransplantationAnnals of Surgery, 1997
- Bridge Experience With Long-term Implantable Left Ventricular Assist DevicesCirculation, 1997
- Left Ventricular Assist Device Infection Is Associated With Increased Mortality but Is Not a Contraindication to TransplantationCirculation, 1997
- Infectious Complications in Left Ventricular Assist Device RecipientsClinical Infectious Diseases, 1997
- Implantable LVAD infections: Implications for permanent use of the deviceThe Annals of Thoracic Surgery, 1996
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993